The DOI matches its Crossref record; 604 of the 604 references it cites were found in a registry or an index.
Central role of mitochondria in drug-induced liver injury
Abstract
A frequent mechanism for drug-induced liver injury (DILI) is the formation of reactive metabolites that trigger hepatitis through direct toxicity or immune reactions. Both events cause mitochondrial membrane disruption. Genetic or acquired factors predispose to metabolite-mediated hepatitis by increasing the formation of the reactive metabolite, decreasing its detoxification, or by the presence of critical human leukocyte antigen molecule(s). In other instances, the parent drug itself triggers mitochondrial membrane disruption or inhibits mitochondrial function through different mechanisms. Drugs can sequester coenzyme A or can inhibit mitochondrial β-oxidation enzymes, the transfer of electrons along the respiratory chain, or adenosine triphosphate (ATP) synthase. Drugs can also destroy mitochondrial DNA, inhibit its replication, decrease mitochondrial transcripts, or hamper mitochondrial protein synthesis. Quite often, a single drug has many different effects on mitochondrial function. A severe impairment of oxidative phosphorylation decreases hepatic ATP, leading to cell dysfunction or necrosis; it can also secondarily inhibit ß-oxidation, thus causing steatosis, and can also inhibit pyruvate catabolism, leading to lactic acidosis. A severe impairment of β-oxidation can cause a fatty liver; further, decreased gluconeogenesis and increased utilization of glucose to compensate for the inability to oxidize fatty acids, together with the mitochondrial toxicity of accumulated free fatty acids and lipid peroxidation products, may impair energy production, possibly leading to coma and death. Susceptibility to parent drug-mediated mitochondrial dysfunction can be increased by factors impairing the removal of the toxic parent compound or by the presence of other medical condition(s) impairing mitochondrial function. New drug molecules should be screened for possible mitochondrial effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, chronic and/or binge alcohol, high fat diets, tobacco smoking, or certain hepatotoxic drugs can directly damage the mitochondrial ETC, producing greater amounts of ROS leaked from the ETS [24], [25], [26], [27].”
Citations
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,197
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
Urano, F., Wang, X.-Z., Bertolotti, A., Zhang, Y.-H., Chung, P., Harding, H., & Ron, D. (2000) · Science · doi:10.1126/science.287.5453.664 · Cited by 3,081
Roles of CHOP/GADD153 in endoplasmic reticulum stress
Oyadomari, S., & Mori, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401373 · Cited by 2,879
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785 · cited 1×
“Genetic differences in CYP expression CYP isoenzymes are under genetic control, and hepatic levels of a given isoenzyme differ considerably in different people (Shimada et al., 1994).”
BackgroundAntiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
Physiological functions of thioredoxin and thioredoxin reductase
Arnér, E. S. J., & Holmgren, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01701.x · Cited by 2,535
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Mitochondria, oxidative stress and cell death
Ott, M., Gogvadze, V. G., Orrenius, S., & Zhivotovsky, B. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0756-2 · Cited by 2,020
Leist, M., Single, B., Castoldi, A. F., Kühnle, S., & Nicotera, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1481 · Cited by 1,871
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29666-5 · Cited by 1,737
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Cantó, C., & Auwerx, J. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328328d0a4 · Cited by 1,624
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M. P., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,601
Germain, R. N. (1994) · Cell · doi:10.1016/0092-8674(94)90336-0 · Cited by 1,431
Fridman, J. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1207116 · Cited by 1,401
Desagher, S., Osen‐Sand, A., Nichols, A. C., Eskes, R., Montessuit, S., Lauper, S., Maundrell, K., Antonsson, B. E., & Martinou, J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.5.891 · Cited by 1,260
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El‐Serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,242
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. II. ROLE OF COVALENT BINDING IN VIVO
Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., & Brodie, B. B. (1973) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29664-1 · Cited by 1,203
The apoptosome: Signalling platform of cell death
Riedl, S. J., & Salvesen, G. S. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2153 · Cited by 1,097
Acetaminophen-Induced Hepatic Necrosis
Jollow, D. J., Thorgeirsson, S. S., Potter, W. Z., Hashimoto, M., & Mitchell, J. R. (2008) · Pharmacology · doi:10.1159/000136547 · Cited by 1,091
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
study, F. T. D., Daly, A. K., Donaldson, P. T., Bhatnagar, P., Shen, Y., Pe’er, I., Floratos, A., Daly, M. J., Goldstein, D. B., John, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.379 · Cited by 1,050
Mitsuya, H., & Broder, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1911 · Cited by 1,041
Molecular mechanisms of quinone cytotoxicity
O'Brien, P. J. (1991) · Chemico-Biological Interactions · doi:10.1016/0009-2797(91)90029-7 · Cited by 1,031
Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., & Leonard, E. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9233 · Cited by 984
Mitochondrial permeability transition and oxidative stress
Kowaltowski, A. J., Castilho, R. F., & Vercesi, A. E. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02316-x · Cited by 832
Antigen-presenting cell function in the tolerogenic liver environment
Thomson, A. W., & Knolle, P. A. (2010) · Nature reviews. Immunology · doi:10.1038/nri2858 · Cited by 830
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829
Mitochondria as regulators of apoptosis: doubt no more
Susín, S. A., Zamzami, N., & Kroemer, G. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00110-8 · Cited by 827
Mitochondrial toxicity of antiviral drugs
Lewis, W., & Dalakas, M. C. (1995) · Nature Medicine · doi:10.1038/nm0595-417 · Cited by 767
Cai, J., & Jones, D. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11401 · Cited by 765
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
Leclercq, I. A., Farrell, G. C., Field, J., Bell, D., Gonzalez, F. J., & Robertson, G. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8814 · Cited by 763
Regulation of apoptosis by endoplasmic reticulum pathways
Breckenridge, D. G., Germain, M., Mathai, J. P., Nguyen, M., & Shore, G. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207108 · Cited by 742
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Pérez-Carreras, M., Del Hoyo, P., Martín, M. A., Rubio, J. C., Martín, A., Castellano, G., Colina, F., Arenas, J., & Solis-Herruzo, J. A. (2003) · Hepatology · doi:10.1002/hep.1840380426 · Cited by 734
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
Shear, N. H., & Spielberg, S. P. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113798 · Cited by 687
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
Galle, P. R., Hofmann, W. J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P. H., & Runkel, L. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.5.1223 · Cited by 686
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity
Fromenty, B., & Pessayre, D. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00012-6 · Cited by 665
Self-citationMitochondrial disease in mouse results in increased oxidative stress
Esposito, L., Melov, S., Panov, A. V., Cottrell, B. A., & Wallace, D. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4820 · Cited by 640
Boehning, D. F., Patterson, R. L., Sedaghat, L., Glebova, N. O., Kurosaki, T., & Snyder, S. H. (2003) · Nature Cell Biology · doi:10.1038/ncb1063 · Cited by 636
Peroxynitrite reactions and formation in mitochondria
Radí, R., Cassina, A., Hodara, R., Quijano, C., & Castro, L. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01111-5 · Cited by 636
Aminotransferase Elevations in Healthy Adults Receiving 4 Grams of Acetaminophen Daily
Watkins, P. B., Kaplowitz, N., Slattery, J. T., Colonese, C. R., Colucci, S. V., Stewart, P. W., & Harris, S. (2006) · JAMA · doi:10.1001/jama.296.1.87 · Cited by 631
McKenzie, R., Fried, M. W., Sallie, R., Conjeevaram, H., Di Bisceglie, A. M., Park, Y., Savarese, B., Kleiner, D., Tsokos, M., Luciano, C., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510263331702 · Cited by 616
Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis
Zong, W., Li, C., Hatzivassiliou, G., Lindsten, T., Yu, Q., Yuan, J., & Thompson, C. B. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302084 · Cited by 611
Implication of free radical mechanisms in ethanol-induced cellular injury
Nordmann, R., Ribière, C., & Rouach, H. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90030-k · Cited by 610
Deniaud, A., Sharaf el dein, O., Maillier, E., Poncet, D., Kroemer, G., Lemaire, C., & Brenner, C. (2008) · Oncogene · doi:10.1038/sj.onc.1210638 · Cited by 586
Dinkova‐Kostova, A. T., Liby, K. T., Stephenson, K. K., Holtzclaw, W. D., Gao, X., Suh, N., Williams, C. R., Risingsong, R., Honda, T., Gribble, G. W., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500815102 · Cited by 575
Begriche, K., Massart, J., Robin, M., Borgne‐Sanchez, A., & Fromenty, B. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.006 · Cited by 566
Self-citationMitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling
Cox, A. G., Winterbourn, C. C., & Hampton, M. B. (2009) · Biochemical Journal · doi:10.1042/bj20091541 · Cited by 550
You, M., Fischer, M., Deeg, M. A., & Crabb, D. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202411200 · Cited by 543
Reactive oxygen species and antioxidant vitamins: Mechanisms of action
Frei, B. B. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90292-5 · Cited by 529
Hanawa, N., Shinohara, M., Saberi, B., Gaarde, W. A., Han, D., & Kaplowitz, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708916200 · Cited by 527
Sulkowski, M., Thomas, D. L., Mehta, S. H., Chaisson, R. E., & Moore, R. D. (2002) · Hepatology · doi:10.1053/jhep.2002.30319 · Cited by 523
Costantini, P., Chernyak, B. V., Petronilli, V., & Bernardi, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6746 · Cited by 516
Tumor Cell Death Induced by Topoisomerase-Targeting Drugs
Li, T., & Liu, L. F. (2001) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.53 · Cited by 509
Mitochondrial abnormalities in non-alcoholic steatohepatitis
Caldwell, S. H., Swerdlow, R. H., Khan, E. M., Iezzoni, J. C., Hespenheide, E. E., Parks, J. K., & Parker, W. D. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80033-6 · Cited by 495
A Fetal Fatty-Acid Oxidation Disorder as a Cause of Liver Disease in Pregnant Women
Ibdah, J. A., Bennett, M. J., Rinaldo, P., Zhao, Y., Gibson, B., Sims, H. F., & Strauss, A. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906033402204 · Cited by 489
Toll–Like Receptor 4 Is Involved in the Mechanism of Early Alcohol–Induced Liver Injury in Mice
Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U., & Thurman, R. G. (2001) · Hepatology · doi:10.1053/jhep.2001.25350 · Cited by 488
Alterations in Liver ATP Homeostasis in Human Nonalcoholic Steatohepatitis
Cortez‐Pinto, H., Chatham, J. C., Chacko, V. P., Arnold, C., Rashid, A., & Diehl, A. M. (1999) · JAMA · doi:10.1001/jama.282.17.1659 · Cited by 487
Lysosomal Membrane Permeabilization Induces Cell Death in a Mitochondrion-dependent Fashion
Boya, P., Andreau, K., Poncet, D., Zamzami, N., Perfettini, J.-L., Metivier, D., Ojcius, D. M., Jäättelä, M., & Kroemer, G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021952 · Cited by 483
Bax and Bak Coalesce into Novel Mitochondria-Associated Clusters during Apoptosis
Nechushtan, A., Smith, C. L., Lamensdorf, I., Yoon, S., & Youle, R. J. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.6.1265 · Cited by 480
C-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity
Gunawan, B. K., Liu, Z., Han, D., Hanawa, N., Gaarde, W. A., & Kaplowitz, N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.045 · Cited by 471
Transcription-independent pro-apoptotic functions of p53
Moll, U. M., Wolff, S., Speidel, D., & Deppert, W. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.007 · Cited by 468
Side effects of high-dose interferon therapy for chronic hepatitis C
Okanoue, T., Sakamoto, S., Itoh, Y., Minami, M., Yasui, K., Sakamoto, M., Nishioji, K., Katagishi, T., Nakagawa, Y., Tada, H., et al. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80113-9 · Cited by 456
Lucena, M. I., Molokhia, M., Shen, Y., Urban, T. J., Aithal, G. P., Andrade, R. J., Day, C. P., Ruiz–Cabello, F., Donaldson, P. T., Stephens, C., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.001 · Cited by 442
Pessayre, D., & Fromenty, B. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.004 · Cited by 441
Self-citationHuang, Y., Chern, H., Su, W., Wu, J., Lai, S., Yang, S., Chang, F., & Lee, S. (2002) · Hepatology · doi:10.1053/jhep.2002.32102 · Cited by 440
Human Fas ligand: gene structure, chromosomal location and species specificity
Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T., & Nagata, S. (1994) · International Immunology · doi:10.1093/intimm/6.10.1567 · Cited by 433
Cytochrome P450 2E1 Genotype and the Susceptibility to Antituberculosis Drug–Induced Hepatitis
Huang, Y., Chern, H., Su, W., Wu, J., Chang, S.-C., Chiang, C., Chang, F., & Lee, S. (2003) · Hepatology · doi:10.1053/jhep.2003.50144 · Cited by 428
Korenaga, M., Wang, T., Li, Y., Showalter, L., Chan, T., Sun, J., & Weinman, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506412200 · Cited by 426
Acetaminophen Hepatotoxicity in Alcoholics: A Therapeutic Misadventure
SEEFF, L. B., CUCCHERINI, B. A., ZIMMERMAN, H. J., ADLER, E., & BENJAMIN, S. B. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-3-399 · Cited by 424
Mitochondrial DNA Mutations and Pathogenesis
Schon, E. A., Bonilla, E., & DiMauro, S. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022685929755 · Cited by 421
Anticonvulsant Hypersensitivity Syndrome
Vittorio, C. C. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430210033005 · Cited by 421
Berhane, K., Widersten, M., Engström, Å., Kozarich, J. W., & Mannervik, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1480 · Cited by 414
Berson, A., de Beco, V., Lettéron, P., Robin, M. A., Moreau, C., Elkahwaji, J. E., Verthier, N., Feldmann, G., Fromenty, B., & Pessayre, D. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70590-6 · Cited by 402
Self-citationToxicity of Antiviral Nucleoside Analogs and the Human Mitochondrial DNA Polymerase
Johnson, A. A., Ray, A. S., Hanes, J. W., Suo, Z., Colacino, J. M., Anderson, K. S., & Johnson, K. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106743200 · Cited by 399
Valproate–Induced Hepatic Injury: Analyses of 23 Fatal Cases
Zimmerman, H. J., & Ishak, K. G. (1982) · Hepatology · doi:10.1002/hep.1840020513 · Cited by 394
Impaired fatty acid oxidation in propofol infusion syndrome
WOLF, A. R., Weir, P., Segar, P., Stone, J., & Hamilton-Shield, J. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04064-2 · Cited by 392
Sutton, A., Khoury, H., Prip‐Buus, C., Cepanec, C., Pessayre, D., & Degoul, F. (2003) · PubMed · doi:10.1097/01.fpc.0000054067.64000.8f · Cited by 389
Self-citationLammert, C. S., Einarsson, S., Saha, C., Niklasson, A., Bjornsson, E. S., & Chalasani, N. (2008) · Hepatology · doi:10.1002/hep.22272 · Cited by 389
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
Singer, J. B., Lewitzky, S., Leroy, E., Yang, F., Zhao, X., Klickstein, L. B., Wright, T. M., Meyer, J. M., & Paulding, C. (2010) · Nature Genetics · doi:10.1038/ng.632 · Cited by 386
Majamaa, K., Moilanen, J. S., Uimonen, S., Remes, A. M., Salmela, P. I., Kärppä, M., Majamaa‐Voltti, K., Rusanen, H., Sorri, M., PEUHKURINEN, K. J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301959 · Cited by 385
Boya, P., Gonzalez-Polo, R.-A., Poncet, D., Andreau, K., Vieira, H. L., Roumier, T., Perfettini, J.-L., & Kroemer, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206622 · Cited by 385
The Role of Keap1 in Cellular Protective Responses
Dinkova‐Kostova, A. T., Holtzclaw, W. D., & Kensler, T. W. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050217c · Cited by 378
Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity
SHEAR, N. H., SPIELBERG, S. P., GRANT, D. M., TANG, B. K., & KALOW, W. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-2-179 · Cited by 373
Cover, C., Mansouri, A., Knight, T. R., Bajt, M. L., Lemasters, J. J., Pessayre, D., & Jaeschke, H. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088898 · Cited by 373
Self-citationErster, S. H., Mihara, M., Kim, R. H., Petrenko, O., & Moll, U. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6728-6741.2004 · Cited by 372
Isoniazid-Associated Hepatitis in 114 Patients
Black, M., Mitchell, J. R., Zimmerman, H. J., Ishak, K. G., & Epler, G. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32568-5 · Cited by 370
Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid
Fulda, S., Scaffidi, C., Susín, S. A., Krammer, P. H., Kroemer, G., Peter, M. E., & Debatin, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33942 · Cited by 370
Kindmark, A., Jawaid, A., Harbron, C. G., Barratt, B. J., Bengtsson, O., Andersson, T. B., Carlsson, S., Cederbrant, K., Gibson, N. J., Armstrong, M., et al. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500458 · Cited by 367
Chloramphenicol in the Newborn Infant
Weiss, C. F., Glazko, A. J., & Weston, J. K. (1960) · New England Journal of Medicine · doi:10.1056/nejm196004212621601 · Cited by 354
Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related Dideoxynucleosides
Oates, J. A., Wood, A. J. J., Yarchoan, R., Mitsuya, H., Myers, C. E., & Broder, S. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909143211106 · Cited by 353
Enzymatic activation of chemicals to toxic metabolites
Guengerich, F. P., Liebler, D. C., & Reed, D. L. (1985) · Critical Reviews in Toxicology · doi:10.3109/10408448509037460 · Cited by 335
Recognition and management of fatty acid oxidation defects: A series of 107 patients
Saudubray, J., Martin, D., de Lonlay, P., Touati, G., Poggi-Travert, F., Bonnet, D., Jouvet, P. A., Boutron, M. C., Slama, A., Vianey‐Saban, C., et al. (1999) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005556207210 · Cited by 330
Rahmani, Z., Huh, K.-W., Lasher, R. S., & Siddiqui, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2840-2846.2000 · Cited by 326
Linezolid-Induced Inhibition of Mitochondrial Protein Synthesis
Vriese, A. S. D., Coster, R. V., Smet, J., Seneca, S., Lovering, A. M., Haute, L. V., Vanopdenbosch, L. J., Martin, J., Groote, C. C., Vandecasteele, S. J., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/501356 · Cited by 325
Beaune, P. H., Dansette, P. M., Mansuy, D., Kiffel, L., Finck, M., Amar, C., Leroux, J. P., & Homberg, J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.551 · Cited by 319
Granzyme B–Mediated Cytochrome C Release Is Regulated by the Bcl-2 Family Members Bid and Bax
Heibein, J. A., Goping, I. S., Barry, M., Pinkoski, M. J., Shore, G. C., Green, D. R., & Bleackley, R. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1391 · Cited by 319
Martin, A. M., Nolan, D. A., JAMES, I. R., Cameron, P. U., Keller, J., Moore, C., Phillips, E. J., Christiansen, F., & Mallal, S. A. (2004) · AIDS · doi:10.1097/00002030-200501030-00014 · Cited by 317
Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice
Masubuchi, Y., Suda, C., & Horie, T. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.015 · Cited by 317
Wit, F. W. N. M., Weverling, G. J., Weel, J. F. L., Jurriaans, S., & Lange, J. M. A. (2002) · The Journal of Infectious Diseases · doi:10.1086/341084 · Cited by 314
Kassahun, K., Pearson, P. G., Tang, W., McIntosh, I., Leung, K., Elmore, C., Dean, D., Wang, R., Doss, G., & Baillie, T. A. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000180q · Cited by 311
Reid, A. B., Kurten, R. C., McCullough, S. S., Brock, R. W., & Hinson, J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075945 · Cited by 302
Polavarapu, R., Spitz, D. R., Sim, J. E., Follansbee, M. H., Oberley, L. W., Rahemtulla, A., & Nanji, A. A. (1998) · Hepatology · doi:10.1002/hep.510270518 · Cited by 301
Ungo, J., Jones, D., Ashkin, D., Hollender, E. S., Bernstein, D. E., Albanese, A., & Pitchenik, A. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9711039 · Cited by 292
HLA association of amoxicillin-clavulanate–induced hepatitis
Hautekèete, M., Horsmans, Y., Waeyenberge, C. V., Demanet, C. J., Henrion, J., Verbist, L., Brenard, R., Sempoux, C. L., Michielsen, P. P., Yap, P. S. H., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70404-x · Cited by 285
Vergani, D., Mieli‐Vergani, G., Alberti, A., Neuberger, J., Eddleston, A. L. W. F., Davis, M. R., & Williams, R. L. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007103030202 · Cited by 284
Metabolic Activation of Drugs to Toxic Substances
Mitchell, J. R., & Jollows, D. J. (1975) · Gastroenterology · doi:10.1016/s0016-5085(75)80025-4 · Cited by 279
Chen, C. H., & Cheng, Y. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80156-9 · Cited by 278
Spraggs, C. F., Budde, L. R., Briley, L. P., Bing, N., Cox, C. J., King, K. S., Whittaker, J. C., Mooser, V., Preston, A. J., Stein, S. H., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3197 · Cited by 277
Lysosomes as “Suicide Bags” in Cell Death: Myth or Reality?
Turk, B., & Türk, V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.023820 · Cited by 276
Hepatotoxicity due to mitochondrial dysfunction
Pessayre, D., Mansouri, A., Haouzi, D., & Fromenty, B. (1999) · Cell Biology and Toxicology · doi:10.1023/a:1007649815992 · Cited by 274
Self-citationMitochondrial Disease: A Practical Approach for Primary Care Physicians
Haas, R., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darín, N., & Cohen, B. H. (2007) · PEDIATRICS · doi:10.1542/peds.2007-0391 · Cited by 272
Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis
Natori, S., Rust, C., Stadheim, L. M., Srinivasan, A. N., Burgart, L. J., & Gores, G. J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00089-1 · Cited by 270
Leonarduzzi, G., Scavazza, A., Biasi, F., Chiarpotto, E., Camandola, S., Vogl, S., Dargel, R., & Poli, G. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.11.9285483 · Cited by 264
Chalasani, N. (2005) · Hepatology · doi:10.1002/hep.20671 · Cited by 264
Co-amoxiclav jaundice: clinical and histological features and HLA class II association
O’Donohue, J., Oien, K. A., Donaldson, P., Underhill, J., Clare, M., MacSween, R. N. M., & Mills, P. R. (2000) · Gut · doi:10.1136/gut.47.5.717 · Cited by 261
Chariot, P., Drogou, I., de Lacroix-Szmania, I., Eliezer‐Vanerot, M., Chazaud, B., Lombès, A., Schaeffer, A., & Zafrani, É. S. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80020-8 · Cited by 259
Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes
Laine, J., Auriola, S. O. K., Pasanen, M., & Juvonen, R. O. (2009) · Xenobiotica · doi:10.1080/00498250802512830 · Cited by 258
Tsutsumi, S., Gotoh, T., Tomisato, W., Mima, S., Hoshino, T., Hwang, H.-J., Takenaka, H., Tsuchiya, T., Mori, M., & Mizushima, T. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401436 · Cited by 256
Nakagawa, H., Maeda, S., Hikiba, Y., Ohmae, T., Shibata, W., Yanai, A., Sakamoto, K., Ogura, K., Noguchi, T., Karin, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.006 · Cited by 255
Oral Medications With Significant Hepatic Metabolism at Higher Risk for Hepatic Adverse Events
Lammert, C. S., Bjornsson, E. S., Niklasson, A., & Chalasani, N. (2009) · Hepatology · doi:10.1002/hep.23317 · Cited by 251
Altered Thiol and Calcium Homeostasis in Oxidative Hepatocellular Injury
Bellomo, G., & Orrenius, S. (1985) · Hepatology · doi:10.1002/hep.1840050529 · Cited by 249
Bédossa, P., Houglum, K., Trautwein, C., Holstege, A., & Chojkier, M. (1994) · Hepatology · doi:10.1002/hep.1840190527 · Cited by 248
A polymorphism in the CYP17 gene increases the risk of breast cancer.
Feigelson, H. S., Coetzee, G. A., Kolonel, L. N., Ross, R. K., & Henderson, B. E. (1997) · PubMed · Cited by 247
Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins
Chipuk, J. E., Fisher, J. C., Dillon, C. P., Kriwacki, R. W., Kuwana, T., & Green, D. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808036105 · Cited by 245
Borutaitė, V., & Brown, G. C. (1996) · Biochemical Journal · doi:10.1042/bj3150295 · Cited by 243
Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition
Jedlitschky, G., Hoffmann, U., & Kroemer, H. K. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.3.351 · Cited by 243
Fernández-Checa, J. C., García‐Ruiz, C., Ookhtens, M., & Kaplowitz, N. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115010 · Cited by 242
Polymerase γ Gene POLG Determines the Risk of Sodium Valproate-Induced Liver Toxicity
Stewart, J. D., Horváth, R., Baruffini, E., Ferrero, I., Bulst, S., Watkins, P. B., Fontana, R. J., Day, C. P., & Chinnery, P. F. (2010) · Hepatology · doi:10.1002/hep.23891 · Cited by 242
Feigelson, H. S., Shames, L. S., Pike, M. C., Coetzee, G. A., Stanczyk, F. Z., & Henderson, B. E. (1998) · PubMed · Cited by 241
Dai, Y., Rashba-Step, J., & Cederbaum, A. I. (1993) · Biochemistry · doi:10.1021/bi00078a017 · Cited by 240
Bartlett, J. G. (1998) · PubMed · Cited by 238
Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection
Wong, W., Wu, P., Yuen, M., Cheng, C.-C., Yew, W.-W., Wong, P.-C., Tam, C. M., Leung, C., & Lai, C. (2000) · Hepatology · doi:10.1002/hep.510310129 · Cited by 231
Mansouri, A., Demeilliers, C., Amsellem, S., Pessayre, D., & Fromenty, B. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29435-0 · Cited by 226
Self-citationWu, J., Wong, W. W.-L., Khosravi, F., Minden, M. D., & Penn, L. Z. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0866 · Cited by 225
Chitturi, S., & Farrell, G. C. (2000) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-000-0034-7 · Cited by 221
Dykens, J. A., Jamieson, J., Marroquin, L., Nadanaciva, S., Billis, P. A., & Will, Y. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.08.013 · Cited by 220 · cited 1×
“At such high intramitochondrial concentrations, phenformin becomes a potent inhibitor of oxygen consumption, ATP formation, and cell survival in HepG2 cells grown on galactose (Dykens et al., 2008a).”
BackgroundAdaptation to Oxidative Stress, Chemoresistance, and Cell Survival
Landriscina, M., Maddalena, F., Laudiero, G., & Esposito, F. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2692 · Cited by 219
Aithal, G. P., Ramsay, L., Daly, A. K., Sonchit, N., Leathart, J. B. S., Alexander, G., Kenna, J. G., Caldwell, J., & Day, C. P. (2004) · Hepatology · doi:10.1002/hep.20205 · Cited by 216
Human mitochondrial topoisomerase I
Zhang, H., Barceló, J. M., Lee, B., Kohlhagen, G., Zimonjic, D. B., Popescu, N. C., & Pommier, Y. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191321998 · Cited by 215
Huang, Y., Su, W., Huang, Y., Chen, C., Chang, F.-Y., Lin, H., & Lee, S. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.009 · Cited by 212
An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice
Mansouri, A., Gaou, I., de Kerguenec, C., Amsellem, S., Haouzi, D., Berson, A., Moreau, A., Feldmann, G., Lettéron, P., Pessayre, D., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70566-4 · Cited by 208
Self-citationKenna, J. G., Satoh, H., Christ, D. D., & Pohl, L. R. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24104-0 · Cited by 208
Ravagnan, L., Marzo, I., Costantini, P., Susín, S. A., Zamzami, N., Petit, P. X., Hirsch, F., Goulbern, M., Poupon, M., Miccoli, L., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202625 · Cited by 207
Bourdi, M., Larrey, D. G., Nataf, J., Bernuau, J., Pessayre, D., Iwasaki, M., Guengerich, F. P., & Beaune, P. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114660 · Cited by 206
Self-citationBröker, L. E., Huisman, C., Span, S. W., Rodríguez, J. A., Kruyt, F. A. E., & Giaccone, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3060 · Cited by 206
Bruno, S., Maisonneuve, P., Castellana, P., Rotmensz, N., Rossi, S., Maggioni, M., Persico, M., Colombo, A., Monasterolo, F., Casadei-Giunchi, D., et al. (2005) · BMJ · doi:10.1136/bmj.38391.663287.e0 · Cited by 201
Dykens, J. A., Jamieson, J. D., Marroquin, L. D., Nadanaciva, S., Xu, J. J., Dunn, M. C., Smith, A. R., & Will, Y. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn056 · Cited by 199
Fagian, M. M., Pereira-da-Silva, L., Martins, I. S., & Vercesi, A. E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45467-6 · Cited by 198
Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax
Fletcher, J. I., Meusburger, S., Hawkins, C. J., Riglar, D. T., Lee, E. F., Fairlie, W. D., Huang, D. C. S., & Adams, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808691105 · Cited by 198
Cationic amphiphilic drugs and phospholipid storage disorder.
Kodavanti, U. P., & Mehendale, H. M. (1990) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00049-3 · Cited by 197
Lucena, M. I., Andrade, R. J., Martínez, C., Ulzurrun, E., García‐Martín, E., Borraz, Y., Fernández, M. C., Romero‐Gómez, M., Castiella, A., Planas, R., et al. (2008) · Hepatology · doi:10.1002/hep.22370 · Cited by 194
DNA Topoisomerases as Anticancer Drug Targets
Schneider, E., Hsiang, Y. H., & Liu, L. F. (1990) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60342-7 · Cited by 193
Textbook of hepatology : from basic science to clinical practice
Rodés, J. (2007) · Cited by 192
Belzacq, A.-S., Hamel, C. E., Vieira, H. L. A., Cohen, I., Haouzi, D., Métivier, D., Marchetti, P., Brenner, C., & Kroemer, G. (2001) · Oncogene · doi:10.1038/sj.onc.1204953 · Cited by 191
Lettéron, P., Sutton, A., Mansouri, A., Fromenty, B., & Pessayre, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50309 · Cited by 189
Self-citationHuman Cytochrome P450 2E1 Is a Major Autoantigen Associated with Halothane Hepatitis
Bourdi, M., Chen, W., Peter, R. M., Martin, J. L., Buters, J., Nelson, S. D., & Pohl, L. R. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960083q · Cited by 189
Role of CHOP in Hepatic Apoptosis in the Murine Model of Intragastric Ethanol Feeding
Ji, C., Mehrian‐Shai, R., Chan, C., Hsu, Y., & Kaplowitz, N. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000174691.03751.11 · Cited by 189
Mechanisms of benzarone and benzbromarone‐induced hepatic toxicity†
Kaufmann, P., Török, M., Hänni, A., Roberts, P. A., Gasser, R., & Krähenbühl, S. (2005) · Hepatology · doi:10.1002/hep.20634 · Cited by 187
de la Asunción, J. G., del Olmo, M. L., Sastre, J., Millan, A., Pellı́n, A., Pallardó, F. V., & Viña, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1418 · Cited by 186
Synthetic polyamine analogs as antineoplastics
Bergeron, R. J., Neims, A. H., McManis, J. S., Hawthorne, T. R., Vinson, J. R. T., Bortell, R., & Ingeno, M. J. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00401a019 · Cited by 186
Emery, M. G., Fisher, J. M., Chien, J. Y., Kharasch, E. D., Dellinger, P. E., Kowdley, K. V., & Thummel, K. E. (2003) · Hepatology · doi:10.1053/jhep.2003.50342 · Cited by 185
Hirata, K., Takagi, H., Yamamoto, M., Matsumoto, T., Nishiya, T., Mori, K., Shimizu, S., Masumoto, H., & Okutani, Y. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500442 · Cited by 184
HIV-associated lipodystrophy: from fat injury to premature aging
Caron, M., Lagathu, C., Boccara, F., Vigouroux, C., & Capeau, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.002 · Cited by 184
Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats
Masubuchi, Y., Nakayama, S., & Horie, T. (2002) · Hepatology · doi:10.1053/jhep.2002.31871 · Cited by 184
Effects of Aspirin and Acetaminophen on the Liver
Zimmerman, H. J. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.3.333 · Cited by 180
Clarke, L., & Waxman, D. J. (1989) · PubMed · Cited by 179
Public Health Service Study on Reye’s Syndrome and Medications
Hurwitz, E. S., Barrett, M. J., Bregman, D. J., Gunn, W. J., Schonberger, L. B., Fairweather, W. R., Drage, J. S., Montagne, J. R. L., Kaslow, R. A., Burlington, D. B., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131403 · Cited by 178
Fromenty, B., Fisch, C., Labbe, G., Degott, C., Deschamps, D., Berson, A., Lettéron, P., & Pessayre, D. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22984-6 · Cited by 178
Self-citationMethotrexate Hepatotoxicity in Psoriasis—Comparison of Different Dose Regimens
Dahl, M. G. C., Gregory, M. M., & Scheuer, P. J. (1972) · BMJ · doi:10.1136/bmj.1.5801.654 · Cited by 177
Hug, H., Strand, S., Grambihler, A., Galle, J., Hack, V., Stremmel, W., Krammer, P. H., & Galle, P. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28191 · Cited by 177
Harrill, A. H., Watkins, P. B., Su, S., Ross, P. K., Harbourt, D. E., Stylianou, I. M., Boorman, G. A., Russo, M. W., Sackler, R. S., Harris, C., et al. (2009) · Genome Research · doi:10.1101/gr.090241.108 · Cited by 177
Poucell, S., Ireton, J., Valencia‐Mayoral, P., Downar, E., Larratt, L. M., Patterson, J., Blendis, L. M., & Phillips, M. J. (1984) · PubMed · Cited by 177
Clinical Syndromes and Consequences of Antiretroviral-Related Hepatotoxicity5, 1, 3
Núñez, M. (2010) · Hepatology · doi:10.1002/hep.23716 · Cited by 176
Diabetes increases the risk of acute hepatic failure
El‐Serag, H. B., & Everhart, J. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.33650 · Cited by 175
Watanabe, I., Tomita, A., Shimizu, M., Sugawara, M., Yasumo, H., Koishi, R., Takahashi, T., Miyoshi, K., Nakamura, K., Izumi, T., et al. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00014-6 · Cited by 174
Apostolova, N., Gómez-Sucerquia, L. J., Moran, A., Álvarez, Á., Blas‐García, A., & Esplugues, J. V. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00866.x · Cited by 173
Role of Fas Ligand in Apoptosis Induced by Hepatitis C Virus Infection
Mita, E., Hayashi, N., Iio, S., Takehara, T., Hijioka, T., Kasahara, A., Fusamoto, H., & Kamada, T. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2483 · Cited by 173
Lewis, W., Copeland, W. C., & Day, B. J. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780288 · Cited by 173
[3] Glutathione biosynthesis and its inhibition
Meister, A. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)52005-8 · Cited by 171
Walker, U. A., Bäuerle, J., Laguno, M., Murillas, J., Mauss, S., Schmutz, G., Setzer, B., Miquel, R., Gatell, J. M., & Mallolas, J. (2004) · Hepatology · doi:10.1002/hep.20074 · Cited by 171
Mallon, P. W. G., Unemori, P., Sedwell, R., Morey, A. L., Rafferty, M., Williams, K., Chisholm, D. J., Samaras, K., Emery, S., Kelleher, A. D., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429697 · Cited by 170
Shekhawat, P., Bennett, M. J., Sadovsky, Y., Nelson, D. M., Rakheja, D., & Strauss, A. W. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00481.2002 · Cited by 170
Iverson, S. L., & Uetrecht, J. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002029 · Cited by 169
Lewis, W., Levine, E. S., Griniuvienė, B., Tankersley, K. O., Colacino, J. M., Sommadossi, J., Watanabe, K. A., & Perrino, F. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3592 · Cited by 169
Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
Eliasson, E., & Kenna, J. G. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09316-2 · Cited by 167
Penzo, D., Petronilli, V., Angelin, A., Cusan, C., Colonna, R., Scorrano, L., Pagano, F. C., Prato, M., Lisa, F. D., & Bernardi, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310381200 · Cited by 166
Nadanaciva, S., Dykens, J. A., Bernal, A. J., Capaldi, R., & Will, Y. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.06.003 · Cited by 166
Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs
Maida, I. R., Núñez, M., Ríos, M. J., Martín‐Carbonero, L., Sotgiu, G., Toro, C., Rivas, P., Barreiro, P., Mura, M. S., Babudieri, S., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000221683.44940.62 · Cited by 165
Perhexiline Maleate-Induced Cirrhosis
Pessayre, D., Bichara, M., Feldmann, G., Degott, C., Potet, F., & Benhamou, J. (1979) · Gastroenterology · doi:10.1016/s0016-5085(79)80145-6 · Cited by 164
Self-citationDNA repair in mammalian mitochondria: Much more than we thought?
Liu, P., & Demple, B. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20576 · Cited by 164
DNA damage by peroxynitrite characterized with DNA repair enzymes
Epe, B. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.21.4105 · Cited by 163
Fromenty, B., Fisch, C., Berson, A., Lettéron, P., Larrey, D. G., & Pessayre, D. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22965-2 · Cited by 163
Self-citation
Flagged first, then by citations
Research works printed but not linked: 33
- Albrecht H., 1995, J Inflamm, 45, 64
- Bedossa P., 1994, Hepatology, 19, 1262
- Brivet F. G., 1999, J Hepatol, 30, 364
- Carini R., 1995, Hepatology, 21, 1089
- Chabrol B., 1994, Eur J Pediatr, 153, 133
- Clarke L., 1989, Cancer Res, 49, 2344
- Cribb A. E., 1996, Adverse Drug React Toxicol Rev, 15, 9
- Curzio M., 1985, Int J Tissue React, 7, 137
- De la Iglesia F. A., 1974, Lab Invest, 4, 539
- Dutertre J. P., 1991, Eur J Gastroenterol Hepatol, 3, 953
- Dybing E., 1976, Mol Pharmacol, 12, 911
- Feigelson H. S., 1997, Cancer Res, 57, 1063
- Feigelson H. S., 1998, Cancer Res, 58, 585
- Grimbert S., 1995, Am J Physiol, 268, G107
- Itoh S., 1977, Acta Hepato-Gastroenterol, 24, 415
- Kent P. D., 2004, J Rheumatol, 31, 1727
- Lettéron P., 1997, Am J Physiol, 272, G1141
- Lillibridge J. H., 1997, Drug Metab Dispos, 24, 509
- Lucena MI, 2011, Gastroenterology
- Moult P. J., 1975, Q J Med, 44, 99
- Nass M. M., 1984, Cancer Res, 44, 2677
- Ohnishi T., 2005, Oncol Rep, 13, 485
- Pessayre D., 1980, Biochem Pharmacol, 29, 219
- Poon G. K., 2001, Drug Metab Dispos, 29, 1608
- 10.1001/jama.1988.03410210079041 · DOI
- Roy S., 1980, Res Commun Chem Pathol Pharmacol, 27, 507
- Susin S A., 1998, Biochim Biophys Acta, 15, 1
- 10.1097/00008571-200303000-00004 · DOI
- Wang M., 1998, Drug Metab Dispos, 26, 98
- Wen B., 2011, Drug Metab Dispos
- Werner S., 1996, Cancer Res, 56, 4391
- Yunis A. A., 1989, Am J Med, 87, N44
- Zhang Z., 1993, Am J Hum Genet, 52, 1111
Cited by
Sorted by citations
Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases
Mansouri, A., Gattolliat, C., & Asselah, T. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.083 · Cited by 839
Self-citationMolecular pathways of nonalcoholic fatty liver disease development and progression
Bessone, F., Razori, M. V., & Roma, M. G. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2947-0 · Cited by 664
The past and present of serum aminotransferases and the future of liver injury biomarkers
McGill, M. R. (2016) · EXCLI journal · doi:10.17179/excli2016-800 · Cited by 488
Mitochondrial alterations in fatty liver diseases
Fromenty, B., & Roden, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.09.020 · Cited by 448
Self-citationDrug-induced liver injury: Interactions between drug properties and host factors
Chen, M., Suzuki, A., Borlak, J. T., Andrade, R. J., & Lucena, M. I. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.016 · Cited by 410
Metadata
- Authors
- Pessayre, D., Fromenty, B., Berson, A., Robin, M.-A., Lettéron, P., Moreau, R., & Mansouri, A.
- Affiliations
- Inserm (FR)
- Corresponding author
- Pessayre, Dominique
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2012-01-30
- Volume
- 44
- Issue
- 1
- Pages
- 34-87
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W2076781542
- Cited by
- 277
- References
- 604
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 11 · 2023: 21 · 2022: 22 · 2021: 31 · 2020: 16 · 2019: 15 · 2018: 26 · 2017: 19 · 2016: 21 · 2015: 26 · 2014: 23 · 2013: 13 · 2012: 2
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Metabolism Reviews (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- drug-induced liver injury, mitochondrial dysfunction, reactive drug metabolites, mitochondrial membrane disruption, oxidative phosphorylation, ATP synthase inhibition, mitochondrial DNA damage, lactic acidosis, hepatic steatosis, steatosis, lipid peroxidation, human leukocyte antigen, genetic susceptibility, drug safety testing
- MeSH terms
- DNA, Mitochondrial, Pharmaceutical Preparations, Fatty Liver, Humans, Immune System, Liver, Mitochondria, Liver, Oxidation-Reduction, Reactive Oxygen Species, Cell Respiration, Mitochondrial Proteins, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review